Invesco Ltd. Mei Pharma, Inc. Transaction History

Invesco Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.42 - $0.65 $16,302 - $25,230	-38,816 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.54 - $2.74 $751 - $3,814	1,392 Added 3.72%	38,816 $23,000
Q4 2021 Feb 14, 2022	SELL	$2.33 - $3.37 $2,516 - $3,639	-1,080 Reduced 2.8%	37,424 $100,000
Q3 2021 Nov 15, 2021	BUY	$2.52 - $2.99 $23,859 - $28,309	9,468 Added 32.61%	38,504 $106,000
Q2 2021 Aug 17, 2021	SELL	$2.6 - $3.65 $33,350 - $46,818	-12,827 Reduced 30.64%	29,036 $83,000
Q1 2021 May 17, 2021	BUY	$2.73 - $4.5 $56,854 - $93,717	20,826 Added 99.0%	41,863 $143,000
Q4 2020 Feb 16, 2021	BUY	$2.6 - $3.32 $54,696 - $69,842	21,037 New	21,037 $56,000
Q1 2019 May 15, 2019	SELL	$2.52 - $3.24 $36,489 - $46,915	-14,480 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.92 - $4.1 $27,801 - $59,367	14,480 New	14,480 $38,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $370M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.